186 related articles for article (PubMed ID: 1627637)
1. Tissue lipid accumulation by L-aminocarnitine, an inhibitor of carnitine-palmitoyltransferase-2. Studies in intact rats and isolated mitochondria.
Chiodi P; Maccari F; Ramacci MT
Biochim Biophys Acta; 1992 Jul; 1127(1):81-6. PubMed ID: 1627637
[TBL] [Abstract][Full Text] [Related]
2. Antiketogenic and hypoglycemic effects of aminocarnitine and acylaminocarnitines.
Jenkins DL; Griffith OW
Proc Natl Acad Sci U S A; 1986 Jan; 83(2):290-4. PubMed ID: 3455765
[TBL] [Abstract][Full Text] [Related]
3. Different sensitivities of CPT I and CPT II for inhibition by l-aminocarnitine in human skeletal muscle.
Traufeller K; Gellerich FN; Zierz S
Biochim Biophys Acta; 2004 Feb; 1608(2-3):149-54. PubMed ID: 14871492
[TBL] [Abstract][Full Text] [Related]
4. Action in vivo and in vitro of 2-tetradecylglycidic acid, 2-tetradecylglycidyl-CoA and 2-tetradecylglycidylcarnitine on hepatic carnitine palmitoyltransferase.
Brady PS; Brady LJ
Biochem J; 1986 Sep; 238(3):801-9. PubMed ID: 3800962
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of carnitine palmitoyltransferase leads to induction of 3-hydroxymethylglutaryl coenzyme A reductase activity in rat liver.
Jansen H; Hoogerbrugge Van der Linden N; Hülsmann WC
Biochim Biophys Acta; 1990 Jun; 1044(3):390-3. PubMed ID: 2364104
[TBL] [Abstract][Full Text] [Related]
6. Aminocarnitine and related compounds as inhibitors of carnitine transferases: physiologic implications.
Nutr Rev; 1990 Jun; 48(6):258-60. PubMed ID: 1365754
[TBL] [Abstract][Full Text] [Related]
7. Accumulation and excretion of long-chain acylcarnitine by rat hearts; studies with aminocarnitine.
Hülsmann WC; Schneijdenberg CT; Verkleij AJ
Biochim Biophys Acta; 1991 Nov; 1097(4):263-9. PubMed ID: 1742330
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of hepatic fatty acid oxidation at carnitine palmitoyltransferase I by the peroxisome proliferator 2-hydroxy-3-propyl-4-[6-(tetrazol-5-yl) hexyloxy]acetophenone.
Foxworthy PS; Eacho PI
Biochem J; 1988 Jun; 252(2):409-14. PubMed ID: 3415664
[TBL] [Abstract][Full Text] [Related]
9. Specific inhibition of mitochondrial fatty acid oxidation by 2-bromopalmitate and its coenzyme A and carnitine esters.
Chase JF; Tubbs PK
Biochem J; 1972 Aug; 129(1):55-65. PubMed ID: 4646779
[TBL] [Abstract][Full Text] [Related]
10. Liver mitochondria, confirmed as intact by complete suppression of succinate uptake and oxidation, possess a carnitine palmitoyltransferase I that is totally inhibited by malonyl CoA.
Abo-Hashema KA; Cake MH; Potter IC
Biochem Biophys Res Commun; 1999 May; 258(3):778-83. PubMed ID: 10329463
[TBL] [Abstract][Full Text] [Related]
11. Changes of hepatic fatty acid metabolism produced by chronic thioacetamide administration in rats.
Nozu F; Takeyama N; Tanaka T
Hepatology; 1992 Jun; 15(6):1099-106. PubMed ID: 1592350
[TBL] [Abstract][Full Text] [Related]
12. Malonyl-CoA binding site and the overt carnitine palmitoyltransferase activity reside on the opposite sides of the outer mitochondrial membrane.
Murthy MS; Pande SV
Proc Natl Acad Sci U S A; 1987 Jan; 84(2):378-82. PubMed ID: 3540964
[TBL] [Abstract][Full Text] [Related]
13. Effect of pH on malonyl-CoA inhibition of carnitine palmitoyltransferase I.
Stephens TW; Cook GA; Harris RA
Biochem J; 1983 May; 212(2):521-4. PubMed ID: 6882380
[TBL] [Abstract][Full Text] [Related]
14. The effects of 2[5(4-chlorophenyl)pentyl]oxirane-2-carbonyl-Co-A on mitochondrial oxidations.
Turnbull DM; Bartlett K; Younan SI; Sherratt HS
Biochem Pharmacol; 1984 Feb; 33(3):475-81. PubMed ID: 6704164
[TBL] [Abstract][Full Text] [Related]
15. Ca2+-mediated action of long-chain acyl-CoA on liver mitochondria energy-linked processes.
Di Lisa F; Menabò R; Miotto G; Bobyleva-Guarriero V; Siliprandi N
Biochim Biophys Acta; 1989 Feb; 973(2):185-8. PubMed ID: 2465024
[TBL] [Abstract][Full Text] [Related]
16. L-carnitine acyltransferase in intact peroxisomes is inhibited by malonyl-CoA.
Derrick JP; Ramsay RR
Biochem J; 1989 Sep; 262(3):801-6. PubMed ID: 2590167
[TBL] [Abstract][Full Text] [Related]
17. Carnitine acyltransferase activities in rat brain mitochondria. Bimodal distribution, kinetic constants, regulation by malonyl-CoA and developmental pattern.
Bird MI; Munday LA; Saggerson ED; Clark JB
Biochem J; 1985 Feb; 226(1):323-30. PubMed ID: 3977877
[TBL] [Abstract][Full Text] [Related]
18. DL-aminocarnitine and acetyl-DL-aminocarnitine. Potent inhibitors of carnitine acyltransferases and hepatic triglyceride catabolism.
Jenkins DL; Griffith OW
J Biol Chem; 1985 Nov; 260(27):14748-55. PubMed ID: 3840486
[TBL] [Abstract][Full Text] [Related]
19. Interacting effects of L-carnitine and malonyl-CoA on rat liver carnitine palmitoyltransferase.
Bird MI; Saggerson ED
Biochem J; 1985 Aug; 230(1):161-7. PubMed ID: 4052033
[TBL] [Abstract][Full Text] [Related]
20. Characterization of L-aminocarnitine, an inhibitor of fatty acid oxidation.
Chegary M; Te Brinke H; Doolaard M; Ijlst L; Wijburg FA; Wanders RJ; Houten SM
Mol Genet Metab; 2008 Apr; 93(4):403-10. PubMed ID: 18077198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
